Carmella Angus is a dental, medical and pharmaceutical C-Level executive and board member whose expertise spans all facets of the healthcare industry, including the manufacturing of dental devices. An expert in profit and loss management, strategic planning, marketing, business and product development, as well as mergers and acquisitions.
Ms. Angus is a dynamic leader and analytical thinker with the vision to develop short and long-term business plans that contribute to a better quality of life through innovative products and materials. Experienced with both top tier global public companies and startup companies. She holds a Bachelor of Science in Nursing (BScN) and a Masters of Science (MSc) from the Faculty of Medicine University of Toronto with a research and development focus on oral facial pain and a Masters of Business (MBA) in Global Management.
CURRENT AND PAST ROLES
2011 - Present: Chief Executive Officer, Director (BOD) and Founder of Nova DenTech Incorporated
2008 - Present: Founder, Chairman of the Board and Shareholder AC Nova Technologies Incorporated, an OTC Company in Canada/USA
2006 - 2008: President for Canada and Interim CEO/COO, as well as Board Director/Investor, for USA Head Office Dentamach International Incorporated [Mergers & Acquistions of Dental Laboratories]
2001 - 2013: President and Director on the Board of Directors for Condo Corporations TSCC #1839
1989 - 2004: Senior Clinical Research Director and Product Strategist, with Top Tier Global Companies, such as AstraZeneca, Warner Lambert and Pharmacia
1986 -1989: Headed the Heart Failure Basic Research Program, located at St. Michael's Hospital Cardiology Research Unit
PHILANTHROPIC AND FUNDRAISING EFFORTS
Carmella Angus is on the Board of Directors of Prime Mentors of Canada and a Member of the Order of the Eastern Star